Logo
x

Search

Subscribe Now

All Posts by Date

Gilead and Precision Biosciences Collaborates to Develop and Commercialize therapies for the Treatment of HBV using ARCUS Technology

Gilead and Precision Biosciences Collaborates to Develop and Commercialize therapies for the Treatment of HBV using ARCUS Technolo...

  • September 13, 2018
Boehringer Ingelheim Acquires Vira Therapeutics Stakes for Development of Immuno- Oncology Viral Therapies

Boehringer Ingelheim Acquires Vira Therapeutics Stakes for Development of Immuno- Oncology Viral Therapies

  • September 13, 2018
Celgene Reports Improvement in Patients with Moderate-to-Severe Plaque Psoriasis with OTEZLA in P-III ESTEEM trial

Celgene Reports Improvement in Patients with Moderate-to-Severe Plaque Psoriasis with OTEZLA in P-III ESTEEM trial

  • September 13, 2018
Regeneron Announces FDA Review Acceptance of EYLEA's sBLA for the treatment of Diabetic Retinopathy

Regeneron Announces FDA Review Acceptance of EYLEA's sBLA for the treatment of Diabetic Retinopathy

  • September 13, 2018
Image

Stay Connected

Join the PharmaShots family of 12000+ subscribers

I accept the Terms and Conditions

Incisive News in 3 Shots.

Contact Us

Our Information

Follow Us

Copyright © 2025 PharmaShots - All Rights Reserved.